Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 2/20 | 0.54 |
| ▸ | PRNP | P04156 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | CCR1 | P32246 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | FERMT2 | Q96AC1 | 4/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | GAK | O14976 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23340476 | 1.00 | NR4A2 (0.54) | NR4A2PRNPPOLBKMT2ARXFP1 | |
| SCHEMBL23340249 | 0.87 | NR4A2 (0.57) | NR4A2KMT2ACCR1CYP1A2FERMT2 | |
| SCHEMBL23904647 | 0.87 | NR4A2 (0.57) | NR4A2KMT2ACCR1CYP1A2FERMT2 | |
| SCHEMBL23904645 | 0.87 | NR4A2 (0.70) | NR4A2PRNPPOLBKMT2ARXFP1 | |
| SCHEMBL23340475 | 0.86 | CCR1 (0.70) | NR4A2CCR1CYP1A2FERMT2 | |
| SCHEMBL23904644 | 0.86 | FERMT2 (0.62) | NR4A2KMT2ACCR1CYP1A2FERMT2 | |
| SCHEMBL27450988 | 0.83 | FERMT2 (0.63) | NR4A2KMT2ACCR1CYP1A2FERMT2 | |
| SCHEMBL23340187 | 0.79 | CYP1A2 (0.64) | NR4A2KMT2ACCR1CYP1A2FERMT2 | |
| SCHEMBL27953778 | 0.76 | CYP1A2 (0.59) | NR4A2KMT2ACCR1CYP1A2FERMT2 | |
| SCHEMBL23340236 | 0.76 | CCR1 (0.72) | NR4A2KMT2ACCR1CYP1A2FERMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021202669-A2 | NUCLEOSIDE AND NUCLEOTIDE CONJUGATE COMPOUNDS AND USES THEREOF | REYOUNG CORPORATION (US) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021202669-A2 | NUCLEOSIDE AND NUCLEOTIDE CONJUGATE COMPOUNDS AND USES THEREOF | REYOUNG CORPORATION (US) | 2021-10-07 | — | — | WO | disclosed |